Open AccessPhase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer
Author(s) -
Aikou Okamoto,
Eiji Kondo,
Toshiaki Nakamura,
Satoshi Yanagida,
Junzo Hamanishi,
Kenichi Harano,
Kosei Hasegawa,
Takeshi Hirasawa,
Kensuke Hori,
Shinichi Komiyama,
Motoki Matsuura,
Hidekatsu Nakai,
Hiroko Nakamura,
Jun Sakata,
Tsutomu Tabata,
Kazuhiro Takehara,
Munetaka Takekuma,
Yoshihiko Yokoyama,
Yasuhiro Kase,
Shuuji Sumino,
Junpei Soeda,
Ajit Suri,
Daisuke Aoki,
Toru Sugiyama
Publication year - 2021
Publication title -
journal of gynecologic oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.358
H-Index - 37
eISSN - 2005-0399
pISSN - 2005-0380
DOI - 10.3802/jgo.2021.32.e16
Subject(s) - medicine , discontinuation , adverse effect , nausea , ovarian cancer , clinical endpoint , common terminology criteria for adverse events , population , phases of clinical research , anemia , oncology , cancer , clinical trial , environmental health